IL130967A0 - Freeze-dried composition of bone morphogenetic protein human mp52 - Google Patents

Freeze-dried composition of bone morphogenetic protein human mp52

Info

Publication number
IL130967A0
IL130967A0 IL13096798A IL13096798A IL130967A0 IL 130967 A0 IL130967 A0 IL 130967A0 IL 13096798 A IL13096798 A IL 13096798A IL 13096798 A IL13096798 A IL 13096798A IL 130967 A0 IL130967 A0 IL 130967A0
Authority
IL
Israel
Prior art keywords
freeze
bone morphogenetic
morphogenetic protein
dried composition
protein human
Prior art date
Application number
IL13096798A
Other languages
English (en)
Original Assignee
Hoechst Marion Roussel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Ltd filed Critical Hoechst Marion Roussel Ltd
Publication of IL130967A0 publication Critical patent/IL130967A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL13096798A 1997-01-30 1998-01-29 Freeze-dried composition of bone morphogenetic protein human mp52 IL130967A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1634997 1997-01-30
PCT/JP1998/000371 WO1998033514A1 (fr) 1997-01-30 1998-01-29 Composition lyophilisee de mp52 humaine de proteines morphogenetiques osseuses

Publications (1)

Publication Number Publication Date
IL130967A0 true IL130967A0 (en) 2001-01-28

Family

ID=11913900

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13096798A IL130967A0 (en) 1997-01-30 1998-01-29 Freeze-dried composition of bone morphogenetic protein human mp52
IL130967A IL130967A (en) 1997-01-30 1999-07-15 Freeze-dried preparation of human morphogenetic MP52 bone protein

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL130967A IL130967A (en) 1997-01-30 1999-07-15 Freeze-dried preparation of human morphogenetic MP52 bone protein

Country Status (22)

Country Link
EP (1) EP0972520B9 (de)
JP (1) JP4209948B2 (de)
KR (1) KR100548107B1 (de)
CN (1) CN1152712C (de)
AP (1) AP983A (de)
AT (1) ATE302021T1 (de)
AU (1) AU737595B2 (de)
BR (1) BR9807537B1 (de)
CA (1) CA2278546C (de)
DE (1) DE69831223T9 (de)
DK (1) DK0972520T3 (de)
EA (1) EA001579B1 (de)
ES (1) ES2244043T3 (de)
HU (1) HU226554B1 (de)
IL (2) IL130967A0 (de)
NO (1) NO322334B1 (de)
NZ (1) NZ336509A (de)
PL (1) PL189381B1 (de)
RS (1) RS49691B (de)
SI (1) SI0972520T1 (de)
TR (1) TR199901832T2 (de)
WO (1) WO1998033514A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4388602B2 (ja) † 1997-02-07 2009-12-24 ストライカー コーポレイション マトリクスを含まない骨形成デバイス、移植片、およびその使用方法
WO2003030873A1 (en) * 2001-10-09 2003-04-17 Cellfactors Plc Therapeutic biological product and method for formation of new vascularised bone
CA2466947C (en) 2001-11-19 2012-05-22 Scil Technology Gmbh A homogeneously coated device having osteoinductive and osteoconductive properties
ATE322916T1 (de) 2002-09-10 2006-04-15 Scil Technology Gmbh Unter verringerter sauerstoffkonzentration mit einem osteoinduktiven protein beschichtetes metallimplantat
EP1651272A1 (de) * 2003-08-05 2006-05-03 Fuji Photo Film B.V. Verwendung von rekombinanter oder synthetischer gelatine als stabilisator in vakzinen
CA2545458A1 (en) * 2003-11-10 2005-05-26 Arriva-Prometic Inc. Dry recombinant human alpha 1-antitrypsin formulation
JP4944010B2 (ja) 2004-03-10 2012-05-30 サイル テクノロジー ゲーエムベーハー コーティングされたインプラント、その製造および使用
US10360287B2 (en) 2015-05-22 2019-07-23 Microsoft Technology Licensing, Llc Unified messaging platform and interface for providing user callouts
US20160344677A1 (en) 2015-05-22 2016-11-24 Microsoft Technology Licensing, Llc Unified messaging platform for providing interactive semantic objects

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3273597D1 (en) * 1981-11-28 1986-11-06 Sunstar Kk Pharmaceutical composition containing interferon in stable state
US5037644A (en) * 1986-10-27 1991-08-06 Cetus Corporation Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
AU663328B2 (en) * 1991-06-21 1995-10-05 Genetics Institute, Llc Pharmaceutical formulations of osteogenic proteins
JP2966592B2 (ja) * 1991-07-20 1999-10-25 萩原 義秀 安定化されたヒトモノクローナル抗体製剤
UA48105C2 (uk) * 1992-02-12 2002-08-15 Біофарм Гезельшафт Цур Біотехнологішен Ентвіклунг Вон Фармака Мбх ФРАГМЕНТ ДНК, ЯКИЙ КОДУЄ БІЛОК РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), РЕКОМБІНАНТНА МОЛЕКУЛА ДНК (ВАРІАНТИ), КЛІТИНА-ХАЗЯЇН (ВАРІАНТИ), СПОСІБ ОДЕРЖАННЯ БІЛКУ РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), БІЛОК РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ (ВАРІАНТИ), АНТИТІЛО АБО ФРАГМЕНТ АНТИТІЛА (ВАРІАНТИ), МОЛЕКУЛА КДНК (ВАРІАНТИ)
CA2093836A1 (en) * 1992-04-24 1993-10-25 Wayne Gombotz Biodegradable tgf-.beta. delivery system for bone regeneration
DE4239877C1 (de) * 1992-11-27 1994-03-17 Boehringer Ingelheim Int Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung
EP0814841B1 (de) * 1995-03-21 2001-12-05 Applied Research Systems ARS Holding N.V. Flüssige hcg-formulierungen
US7235527B2 (en) * 1995-04-19 2007-06-26 Biopharm Gesellschaft Zur Biotechnologieschen Entwicklung Von Pharmaka Mbh Protein and process for producing the same

Also Published As

Publication number Publication date
SI0972520T1 (sl) 2006-02-28
DE69831223T9 (de) 2006-12-07
EA199900694A1 (ru) 2000-04-24
WO1998033514A1 (fr) 1998-08-06
HUP0002386A2 (hu) 2000-11-28
ES2244043T3 (es) 2005-12-01
CA2278546A1 (en) 1998-08-06
HUP0002386A3 (en) 2002-09-30
NO993702D0 (no) 1999-07-29
RS49691B (sr) 2007-12-31
DE69831223T2 (de) 2006-02-16
NO993702L (no) 1999-09-29
BR9807537A (pt) 2000-03-21
NZ336509A (en) 2001-03-30
KR20000070586A (ko) 2000-11-25
EP0972520B1 (de) 2005-08-17
ATE302021T1 (de) 2005-09-15
BR9807537B1 (pt) 2009-01-13
AU5679198A (en) 1998-08-25
DK0972520T3 (da) 2005-12-19
AP9901602A0 (en) 1999-09-30
KR100548107B1 (ko) 2006-02-02
DE69831223D1 (de) 2005-09-22
TR199901832T2 (xx) 1999-12-21
NO322334B1 (no) 2006-09-18
CN1244127A (zh) 2000-02-09
AU737595B2 (en) 2001-08-23
IL130967A (en) 2006-12-10
YU34999A (sh) 2002-08-12
JP4209948B2 (ja) 2009-01-14
EA001579B1 (ru) 2001-06-25
CA2278546C (en) 2008-04-01
EP0972520A4 (de) 2002-11-05
PL334852A1 (en) 2000-03-27
HU226554B1 (en) 2009-03-30
EP0972520A1 (de) 2000-01-19
CN1152712C (zh) 2004-06-09
AP983A (en) 2001-07-16
PL189381B1 (pl) 2005-07-29
EP0972520B9 (de) 2006-03-22

Similar Documents

Publication Publication Date Title
AU3866097A (en) Naphtholactams and lactones as bone morphogenetic protein active agents
EG22500A (en) Use of an encapsulated bioactive composition
HUP9902187A3 (en) Diaphysial cortical dowel
EP1047442A4 (de) Knochenmorphogeneseproteinen und ihre anwendung zur förderung des knochenwachstums
ZA989461B (en) Methods and compositions for the treatment of autoimmune disease using heat shock proteins
HUP9802556A3 (en) Use of bone morphogenetic protein (bmp) for regeneration of functional connection of bone and tendon or ligament
EP1039801A4 (de) 207 menschliche sekretierte proteine
PL339463A1 (en) April - novel protein of growth promoting action
EP1000084A4 (de) 123 vom menschen abgesonderte proteine
EP0975371A4 (de) Antisense oligonukleotidzusammensetzungen und verfahren zur modulation des aktivierenden proteins 1.
EP1095159A4 (de) Knochenmorphogenese-protein
EP1040117A4 (de) 110 menschliche sekretierte proteines
EP1019091A4 (de) 50 menschliche sekretierte proteine
EP1005544A4 (de) 70 menschliche, sekretierte proteine
HUP9603373A3 (en) Cosmetic composition for artificial tanning and its use
IL130967A0 (en) Freeze-dried composition of bone morphogenetic protein human mp52
EP1027430A4 (de) 64 menschliche sekretierte proteine
EP1032838A4 (de) 125 menschliche sekretierte proteine
AU7115996A (en) Uses of bone morphogenetic proteins
EP1009766A4 (de) 19 menschlisch, sekretierte proteine
AU6245898A (en) Injectable formulations for treatment of osteoporotic bone
EP1042674A4 (de) 148 menschliche sekretierte proteine
EP0691349A3 (de) Dimere Knochenmorphogeneseproteine und ihre Fragmente und Analoge und sie enthaltende pharmazeutische Zubereitungen
EP1017707A4 (de) 29 menschliche sekretierte proteine
EP1003763A4 (de) 83 vom menschen freigesetzte proteine

Legal Events

Date Code Title Description
KB Patent renewed
FF Patent granted
KB Patent renewed